Cheryl Lewis

6.7k total citations · 1 hit paper
53 papers, 1.7k citations indexed

About

Cheryl Lewis is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Cheryl Lewis has authored 53 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Cheryl Lewis's work include Epigenetics and DNA Methylation (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (5 papers). Cheryl Lewis is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (5 papers). Cheryl Lewis collaborates with scholars based in United States, United Kingdom and Canada. Cheryl Lewis's co-authors include David Euhus, Dawei Bu, Sara Milchgrub, John D. Minna, A. Marilyn Leitch, William S. Weintraub, Paul Kolm, Claudine Jurkovitz, Leslie Cler and Robert A. O’Rourke and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Cheryl Lewis

51 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of PCI on Quality of Life in Patients with Stable Coronary Disease

2008 434 citations Cheryl Lewis et al. profile →

Peers

Cheryl Lewis

CCM

SURGE

ONCOL

Yumei Gu China

Janusz Kowalewski Poland

Anne M. Deschamps United States

Naoki Watanabe Japan

Christian Gerdes Denmark

Takeo Tanaka Japan

Tsuyoshi Honda Japan

Andreea C. Popescu Romania

Cuong V. Nguyen United States

Mamiko Kai Japan

Yumei Gu China

Cheryl Lewis

849 ×1.0

229 ×0.6

CCM

373 ×1.1

209 ×0.7

SURGE

379 ×1.4

ONCOL

Citations per year, relative to Cheryl Lewis Cheryl Lewis (= 1×) peers Yumei Gu

Countries citing papers authored by Cheryl Lewis

Since Specialization

Citations

This map shows the geographic impact of Cheryl Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Lewis more than expected).

Fields of papers citing papers by Cheryl Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Lewis. The network helps show where Cheryl Lewis may publish in the future.

Co-authorship network of co-authors of Cheryl Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Lewis. A scholar is included among the top collaborators of Cheryl Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Lewis. Cheryl Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suresh, Shruthy, Lisa Thomas, Cheryl Lewis, et al.. (2025). The Integrated Stress Response Pathway Coordinates Translational Control of Multiple Immune Checkpoints in Lung Cancer. Cancer Research. 85(14). 2574–2590. 2 indexed citations

Deng, Mi, Xiaoye Liu, Ryan Huang, et al.. (2025). Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development. Cancer Immunology Research. 13(6). 821–835. 1 indexed citations

Yang, Xiaofeng, Jingjing Xie, Xiaoye Liu, et al.. (2025). Secretogranin 2 binds LILRB4 resulting in immunosuppression. Nature Immunology. 26(9). 1567–1580. 3 indexed citations

Arshad, Aysha, et al.. (2025). Partial upper sternotomy vs full median sternotomy in obese patients undergoing aortic valve replacement: A meta-analysis. World Journal of Cardiology. 17(9). 110838–110838.

Herrera, L, Pravat Kumar Parida, Suvranil Ghosh, et al.. (2024). AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer. Cancer Research. 84(5). 675–687. 7 indexed citations

Chen, Hao, Kyle Molberg, Kelley Carrick, et al.. (2024). Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma. Modern Pathology. 37(8). 100532–100532. 4 indexed citations

Palakurthi, Bhavana, Ian H. Guldner, Xiyu Liu, et al.. (2023). Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature Communications. 14(1). 2109–2109. 30 indexed citations

Khan, Shahanshah, Youn-Tae Kwak, Lan Peng, et al.. (2023). NLRP12 downregulates the Wnt/β-catenin pathway via interaction with STK38 to suppress colorectal cancer. Journal of Clinical Investigation. 133(19). 19 indexed citations

Ganguly, Debolina, Marcel O. Schmidt, Noah Sorrelle, et al.. (2023). Pleiotrophin drives a prometastatic immune niche in breast cancer. The Journal of Experimental Medicine. 220(5). 8 indexed citations

10.

Wang, Zixi, Shijia Zhu, Yuemeng Jia, et al.. (2023). Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease. Cell. 186(9). 1968–1984.e20. 41 indexed citations

11.

Zhao, Jiawei, Yuemeng Jia, Shunli Shen, et al.. (2020). Merkel Cell Polyomavirus Small T Antigen Activates Noncanonical NF-κB Signaling to Promote Tumorigenesis. Molecular Cancer Research. 18(11). 1623–1637. 20 indexed citations

12.

Lou, Tzu‐Fang, Patrick Dospoy, Hyun Seok Kim, et al.. (2015). Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. Cancer Prevention Research. 9(1). 43–52. 34 indexed citations

13.

Bu, Dawei, Cheryl Lewis, Venetia Sarode, et al.. (2013). Identification of Breast Cancer DNA Methylation Markers Optimized for Fine-Needle Aspiration Samples. Cancer Epidemiology Biomarkers & Prevention. 22(12). 2212–2221. 11 indexed citations

14.

Bey, Erik A., Kathryn E. Reinicke, Melissa C. Srougi, et al.. (2013). Catalase Abrogates β-Lapachone–Induced PARP1 Hyperactivation–Directed Programmed Necrosis in NQO1-Positive Breast Cancers. Molecular Cancer Therapeutics. 12(10). 2110–2120. 84 indexed citations

15.

Hill, Victoria, Christopher J. Ricketts, Ivan Bièche, et al.. (2011). Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity. Cancer Research. 71(8). 2988–2999. 126 indexed citations

16.

Bu, Dawei, Venetia Sarode, Raheela Ashfaq, et al.. (2011). Tamoxifen Downregulates Ets Oncogene Family Members ETV4 and ETV5 in Benign Breast Tissue: Implications for Durable Risk Reduction. Cancer Prevention Research. 4(11). 1852–1862. 13 indexed citations

17.

Gao, Boning, Xian‐Jin Xie, David S. Shames, et al.. (2008). RASSF1A Polymorphism A133S Is Associated with Early Onset Breast Cancer in BRCA1/2 Mutation Carriers. Cancer Research. 68(1). 22–25. 40 indexed citations

18.

Bu, Dawei, et al.. (2006). An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Research and Treatment. 99(3). 257–265. 27 indexed citations

19.

Lewis, Cheryl, Dawei Bu, Adam W. Beck, et al.. (2006). Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier. Breast Cancer Research and Treatment. 99(1). 103–115. 10 indexed citations

20.

Virmani, Arvind K., Asha Rathi, Kenji Sugio, et al.. (2003). Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. International Journal of Cancer. 107(3). 341–345. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact